Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin vs Comparator in Prosthetic Joint Infection
NCT00428844Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2007
- Primary completion
- Mar 2010
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of daptomycin in osteomyelitis (OM), prosthetic joint infection (PJI), sponsored by Merck & Co.. Started Jun 2007; status: completed.
02
Drugs
daptomycin
03
Conditions
osteomyelitis (OM)prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT00428844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00428844.